Showing results (41-50 of 254) with videos related to

Sort By:
Pageof 26
Microbiology Spectrum|November 21, 2022
Two-Period Study Results from a Large Italian Hospital Laboratory Attesting SARS-CoV-2 Variant PCR Assay EvolutionFlora Marzia Liotti, Flavio De Maio, Chiara Ippoliti, et al.
Topics in Antiviral Medicine|June 5, 2025
2025 update of the drug resistance mutations in HIV-1Annemarie M Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2025
Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug ResistanceAnnemarie M Wensing, Charlotte Charpentier, Vincent Calvez, et al.
Journal of Virology|May 22, 2009
Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism Leu-214 on replication capacity and drug susceptibilityMaria Carmen Puertas, Maria Jose Buzón, Anna Artese, et al.
Microorganisms|February 25, 2022
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario?Mohammad Alkhatib, Maria Concetta Bellocchi, Greta Marchegiani, et al.
Antiviral Therapy|May 12, 2009
Historical resistance profile helps to predict salvage failureMauro Zaccarelli, Patrizia Lorenzini, Francesca Ceccherini-Silberstein, et al.
Molecular Pharmacology|June 18, 2005
The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide AJoeri Auwerx, Fátima Rodríguez-Barrios, Francesca Ceccherini-Silberstein, et al.
International Journal of Antimicrobial Agents|March 4, 2023
Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor-based regimenRossana Scutari, Laura Galli, Claudia Alteri, et al.
The Journal of Antimicrobial Chemotherapy|April 9, 2011
Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patientsIsabelle Malet, Marc Wirden, Slim Fourati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 1, 2021
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 studyVincenza Calvaruso, Salvatore Petta, Donatella Ferraro, et al.
Pageof 26